Faricimab, CAS 1607793-29-2

Description: Faricimab, a bispecific antibody, simultaneously targets angiopoietin-2 and vascular endothelial growth factor-A (VEGF-A), and is utilized in research on diabetic macular edema (DME) [1].

CAS Number: 1607793-29-2

• SKU: TGMT78253-5mg
• Manufacturer: TargetMol Chemicals
• Manufacturer SKU: T78253-5mg
• Green Labware: No
• Package Unit: 5 mg
• Quantity Unit: STK